HYPAQUE by GE HealthCare is clinical pharmacology retrograde introduction of hypaque-cysto solution provides radiopacity of the contents of the urinary bladder. First approved in 1956.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
HYPAQUE (diatrizoate meglumine) is a water-soluble iodinated contrast medium administered orally or rectally to opacify the urinary bladder and lower urinary tract for diagnostic imaging. It enables visualization of bladder function, cystoureteric reflux, and lower urinary tract anatomy during fluoroscopic examination. The contrast agent provides radiopacity without systemic absorption when confined to the urinary tract, though intravascular entry is possible with potential for systemic effects.
Product approaching loss of exclusivity with moderate competitive pressure (30), indicating transition from growth to defensive strategies and potential workforce consolidation on the brand team.
CLINICAL PHARMACOLOGY Retrograde introduction of HYPAQUE-CYSTO solution provides radiopacity of the contents of the urinary bladder. When used during micturation as a function test, it also opacifies the bladder neck and lower urinary tract. Continuous fluoroscopic and monitoring of urinary bladder…
Worked on HYPAQUE at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career opportunities on HYPAQUE reflect a mature diagnostic product under GE HealthCare ownership, with 1,106 linked roles concentrated in technical infrastructure, commercial operations, and project management rather than clinical development. Professional growth focuses on operational optimization and customer support for a legacy product facing competitive and lifecycle pressures.
1106 open roles linked to this drug